Lasik provided by Karsaliakou Georgia
The “LASIK Keratomileusis” is the most widely used refractive surgery today.
LASER is applied under a very fine corneal flap which is created with a highly precise micrometre tool and which, after applying the LASER, is repositioned in place.
LASER works by removing tissue with amazing precision and the final result is a perfectly shaped cornea, which allows light to accurately focus on the retina.
Starting on the very next day, the vision improves spectacularly and it is fully restored in about a week.The patient usually returns to work after 3-5 days. The surgery is not painful, since it is performed with anaesthetic drops and there may be only a small annoyance, afterwards.
Individuals with a refractive disorder are not all suitable candidates for refractive surgery.Some of the necessary conditionsfor patients are the following: they must have completed 18 years of age in order for their development to be complete – and, consequently their refractive error –; their correction should be stable for at least one year prior to surgery; they should stop using contact lenses for 15 days; and they should suffer from systemic conditions such as collagens, severe rheumatic diseases or chronic active corneal or retinal diseases.
Surgery should always be performed after a thorough preoperative assessment and by paying great attention to the details, in order for the likelihood of complications to be minimized.
As with any kind of surgery, there is, theoretically, a list of complications ranging from simple to more serious, the incidence of which is particularly low, given the current aseptic and preventive measures.
Complicationsinclude infection, allergy, complications related to the position and architecture of the flap or the corneal layer (tension), and theyare all treatable and do not lead to the loss of vision. In any case, however, the doctor’s instructions should be strictly followed after surgery.
Dr. Georgia Karsaliakou is a Scientific Associate at the Opthalmology Department of “Policliniki” Hospital and Head of Ophthalmological Prevention at the “Hygeia” Hospital in Athens since 2011. Moreover, she has a private practice in Athens, Greece.
In 2000, Dr. Georgia Karsaliakou graduated from the Faculty of Medicine of the National and Kapodistrian University of Athens and further specialized for three months in three different sectors (Cardiology, Pathology and Surgery) of the Panarcadian General Hospital of Tripolis. From February 2001 until August 2002, she served her traineeship at the Regional Medical Center in Nestani, Arcadia. In the meantime, she was on duty on-call at the emergency unit of the Pathology sector, the Hemodialysis unit and the ICU of the Panarcadian General Hospital in Tripolis. Having completed her service, for a year, Dr Georgia Karsaliakou applied medical laser at a specialized aesthetic center. From 2003 until 2005, she worked as an assistant ENT surgeon at a private clinic. In 2010, she concluded her specialization in Ophthalmology at the “Policliniki” Hospital in Athens. For a semester, she followed retinal detachment - vitrectomy surgical procedures at the Ophthalmology Clinic of Retina – Vitreous Components Microsurgery as assistant surgeon, under the Direction of Mr. Ilias Feretis, in “Red Cross” Hospital.
Dr. Karsaliakou holds the position of Scientific Associate at the Ophthalmology Department of “Policliniki” Hospital and is also Head of Ophthalmological Prevention at the “Hygeia” Hospital in Athens. Moreover, she has a private practice in Athens.
She specializes in refractive surgery in order to correct myopia, hypermetropia or astigmatism, using laser at the corneal level. More specifically, Dr.Karsaliakou has extensive experience in corneal surgery with LASER technology that forms- sculpts the corneal shape, so that the vision is again normal and the person who has undergone the surgery is able to see as well at a long distance as seeing while wearing spectacles or contact lenses, without, of course, having to use these devices.
- “Intravitreal infusion of Ranibizumab and photocoagulation in the treatment of the diabetic macular edema.”, Kyriakos Ν. ,Κaramountzos, Κ. Κarsaliakou, G. Xenopoulos, D. Lambrinaki, E. Lambrinakis I., at the 43rd Panhellenic Opthalmology Conference, Thessaloniki
- “Intravitreal infusion of Ranibizumab in the treatment of the macular edema, caused by a thrombosis of a vein of the retina.”, Lambrinakis Ι.Κ., Voutsinas P., Karsaliakou G., Datseris Ι., Κaramountzos Κ., Xenopoulos D., Kyriakos N., LAmbrinaki E.I., Announcement at the 42nd Panhellenic Opthalmology Conference
- “Assisted treatment of blepharitis - dry eye”, Kontogiorgi K., Trakos N., Matziris M., Karamountzos K., Philip M., Karsaliakou G., Xenopoulos D., Lambrinakis I.K., E-Poster at the 42nd Panhellenic Ophthalmology Conference
- “Compliance in the treatment of patients with a primary open angle glaucoma”, Politis A.,Tomais G., Κarsaliakou G., Karamountzos K., Kazopoulos A., Lambrinaki Ε., MatzirisΜ., Xenopoulos D., Lambrinakis Ι.Κ,. E-Poster at the 42nd Panhellenic Ophthalmology Conference
- “Intravitreal infusion of Ranibizumab and photocoagulation in the treatment of the diabetic macular edema.”, Lambrinakis Ι.Κ., Κaramountzos Κ., Κonstantinidou V., Κarsaliakou G., Xenopoulos D., Announcement at the Spring Meeting of the Western Greece - Peloponnese Ophthalmological Society
- Member of the Hellenic Society of Opthalmology
- Member of the European Society of Opthalmology